Assistant Professor of Sociology at the University of Miami
Pro to the question "Should Prescription Drugs Be Advertised Directly to Consumers?"
"Prescription drug advertisements spread valuable educational information about the promoted product and conditions associated with the drug. Better-educated patients can make well-informed decisions regarding their own health care...
DTCA [direct-to-consumer advertisements] can motivate patients to bring to physicians' attention the information they receive about diseases and products in advertisements... Constraints on physicians' time make it vital for patients to be educated outside of the physician's office so that they can use the time with their physicians as effectively as possible... DTCA also motivates patients to disclose difficult to discuss issues, particularly for highly stigmatized diseases such as depression and attention-deficit/hyperactivity disorder.
The positive effects of DTCA on patients are grounded in evidence. These effects include greater involvement in medical decision-making, increased compliance with prescription medication intake, and improved patient-physician communication, which may lead to the diagnosis of previously undiagnosed medical conditions."
"Direct-to-Consumer Advertising of Prescription Drugs Can Inform the Public and Improve Health," Journal of the American Medical Association (JAMA) Oncology, Nov. 2016
Experts Individuals with MDs, DOs, PhDs, MPHs, or equivalent advanced degrees in fields relevant to pharmaceutical drugs and public health. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to pharmaceutical drugs and public health.
Involvement and Affiliations:
Assistant Professor, Muhlenberg College, July 2018-present
Assistant Professor of Sociology, University of Miami, 2013-present
Adjunct Professor, Department of Sociology, Furman University, 2011-2012
Teaching Assistant, Brown University, 2008-2009
MPH, Health Policy and Management, Harvard School of Public Health, 2013
"Direct-to-Consumer Advertising of Prescription Drugs Can Inform the Public and Improve Health," JAMA Oncology, Nov. 2016
"Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis," Journal of Medical Internet Research, Feb. 2016
Cowritten with Phil Brown, et al., "Embodied Health Movements," Contested Illnesses: Citizens, Science, and Health Social Movements, 2011
Cowritten with Mary Fennell, "U.S. Healthcare Organizations: Complexity, Turbulence and Multilevel Change," Annual Review of Sociology, Aug. 2011
Cowritten with Adam Rafalovich, "Cease-and-Desist Regulation and Reintegrative Shaming: The Case of the Direct-To-Consumer Advertising of Prescription Drugs," Free Inquiry in Creative Sociology, May 2007